Recruiting Prostate Cancer Studies in Salisbury
High Dose Testosterone for ATM, CDK12 or CHEK2 Altered Prostate Cancers
This study will determine whether the presence of DNA repair deficiency in the form of alterations in the genes ATM, CDK12 or CHEK2 predicts for a high likelihood of responding to the use of intermitt...
Fatty Acid Synthase Inhibition in Castration Refractory Prostate Cancer
The purpose of this research study is to find out what effects (good and bad) omeprazole and cabazitaxel, or omeprazole and docetaxel, has on participants and their condition. Investigators believe om...
About Prostate Cancer Clinical Trials in Salisbury
Prostate cancer develops in the prostate gland and is one of the most common cancers in men. Many prostate cancers grow slowly, but some can be aggressive. Treatment options range from active surveillance to surgery, radiation, and hormone therapy.
There are currently 2 prostate cancer clinical trials recruiting participants in Salisbury, NC. These studies are seeking a combined 101 participants. Research is being sponsored by VA Office of Research and Development, Wake Forest University Health Sciences. Clinical trial participation is free and participants receive study-related medical care at no cost.
Prostate Cancer Clinical Trials in Salisbury — FAQ
Are there prostate cancer clinical trials in Salisbury?
Yes, there are 2 prostate cancer clinical trials currently recruiting in Salisbury, NC. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Salisbury?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Salisbury research site will contact you about next steps.
Are clinical trials in Salisbury free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Salisbury studies also compensate for your time and travel.
What prostate cancer treatments are being tested?
The 2 active trials in Salisbury are testing new therapies including novel drugs, biologics, and treatment approaches for prostate cancer.
Data updated March 2, 2026 from ClinicalTrials.gov